Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Braveheart Bio, Inc.
Market Cap
$1.45B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Earnings Per Share (EPS)
-5.84
TTM Avg
-6.06
3Y Avg
-7.62
5Y Avg
-6.71
Market Cap
$1.44B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.05
3Y Avg
-2.66
5Y Avg
-2.66
Market Cap
$1.46B
Earnings Per Share (EPS)
1.71
TTM Avg
0.68
3Y Avg
0.58
5Y Avg
0.72
Market Cap
$1.42B
Earnings Per Share (EPS)
5.37
TTM Avg
-2.79
3Y Avg
-4.06
5Y Avg
-3.18
Market Cap
$1.45B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.42B
Earnings Per Share (EPS)
0.90
TTM Avg
0.79
3Y Avg
0.56
5Y Avg
0.48
Market Cap
$1.47B
Earnings Per Share (EPS)
-3.04
TTM Avg
-3.32
3Y Avg
-2.31
5Y Avg
-2.31
Market Cap
$1.48B
Earnings Per Share (EPS)
-1.00
TTM Avg
-0.77
3Y Avg
-0.59
5Y Avg
-0.43
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.45B | N/A | N/A | N/A | N/A |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -5.84 | -6.06 | -7.62 | -6.71 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | -2.74 | -3.05 | -2.66 | -2.66 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 1.71 | 0.68 | 0.58 | 0.72 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.37 | -2.79 | -4.06 | -3.18 |
| Certara, Inc. (CERT)vs › | $1.45B | -0.44 | -0.04 | -0.09 | -0.12 |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 0.90 | 0.79 | 0.56 | 0.48 |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | -3.04 | -3.32 | -2.31 | -2.31 |
| GH Research PLC (GHRS)vs › | $1.48B | -1.00 | -0.77 | -0.59 | -0.43 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | N/A | -1.26 | -1.26 | -1.26 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
